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Objective: We aimed to evaluate the prognostic values, contribution and interactions of the
peripheral blood plasma glutamate and tumor-necrosis factor-a (TNF-a) levels toward the
formation of the perifocal edema in patients with intracerebral hemorrhage (ICH).
Methods: Fifty patients with ICH and ﬁfty healthy controls were included in the study. The
peripheral markers were detected by high-sensitivity ELISA.
Results: A highly signiﬁcant differences in plasma glutamate and TNF-a levels with good
separation of their values was detected between patients and healthy controls. The two
variables correlated with the severity of the symptoms and the initial volume of the ICH at
admission. Both peripheral glutamate and TNF-a levels at admission were estimated as
signiﬁcant predictors for the formation of the perifocal edema ﬁve days after ICH; never-
theless, it was shown that they independently contribute to the development of the edema,
without effects of interaction and regardless the localization of the ICH.
Conclusions: Our results support the idea for the signiﬁcance of glutamate and TNF-a as
peripheral markers for excitotoxicity and inﬂammation in ICH patients. The developed
multiple regression model for prediction of the development of the edema could be beneﬁ-
cial in decision making between conservative treatment and surgical intervention in the
clinical practice.
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Intracerebral hemorrhage (ICH) accounts for 10–15% of strokes
[1]. It is the deadliest subtype of stroke associated with worse
neurological outcome when compared to the ischemic stroke,
with mortality rate of 37–52% after 30 days [2] and in-hospital
mortality of 40% [3].
The biggest neurological deterioration after ICH occurs due
to the formation of the perihematomal edema, a proven
signiﬁcant predictor for bad neurological outcome [4]. The
long-standing dilemma whether patients should be treated
with conservative treatment or surgical intervention was a
matter of subject years ago [5]; nevertheless, the results from
the international STICH study have shown no overall beneﬁt
from early surgery when compared to the initial conservative
treatment [6], leaving the clinicians with the same problem of
decision making without any obvious direction. Therefore, the
search for a molecular marker that could predict the formation
of the edema is a major challenge, because these patients can
be treated in advance with potent anti-edematous therapy or
early craniotomy, thus preventing neurological deteriorations
and future bad outcome.
In the last several years, the focus of the interests for
intervention in ICH has slowly shifted from the acute to the
post-hemorrhagic phase [7]. Several animal models for
experimental ICH have been developed [8,9], and the pre-
clinical studies using these models have revealed that the
secondary brain injury after ICH is mainly triggered by
inﬂammatory mechanisms and formation of peri-hematomal
edema [10–12]. All of these studies have reported increased
levels of pro-inﬂammatory mediators immediately after the
bleeding [13,14], with the tumor necrosis factor-a (TNF-a)
being argued as one of the major constituents of this process
[7]. On the other side, contrary to the ischemic stroke, the
contribution of excitotoxicity in the development of brain
injury after ICH has not been well deﬁned [15]. Several studies
have shown higher glutamate levels in the brain of experi-
mental animals with induced ICH [16] and in the perihema-
tomal area in patients with deep ICH [17], suggesting that
excitotoxicity may also contribute to the secondary brain
injury. However, their interaction with the other primary
mechanisms of brain injury has not been studied in details.
A vast number of pre-clinical studies have shown the effect of
TNF-a on the secondary brain injury in animal models of ICH, but
however detailed clinical studies that evaluate their role in
patients are very rare. An increased variability of the blood–brain
barrier (BBB) has been reported after ICH [18], leading to the
hypothesis that the excitotoxic and pro-inﬂammatory mediators
can transfer from the brain in the blood and be detected
peripherally. The fact that plasma glutamate concentration can
reﬂect the released glutamate levels from the brain tissue in
patients with ischemic stroke [19] supports this hypothesis.
The aim of the present study is to evaluate the role of
peripheral plasma glutamate and TNF-a levels as biomarkers
for ICH, in respect to the anatomic localization of ICH, the
hemispheric side, the symptom severity and the initial volume
of ICH, and moreover, to examine the prognostic role and
possible interactions of these variables on the development of
the volume of the edema ﬁve days after ICH.2. Methods
2.1. Subjects and study design
We have included 50 patients with acute, primary, supra-
tentorial ICH, recruited from the University clinics of
Neurosurgery and Neurology and 50 healthy controls in the
period from 01.01.2014 to 31.10.2016. The study was approved
by the Ethical committee and all subjects have given
informed consent.
For the purposes of the initial screening, all subjects were
called for a short conversation and their medical history as
well as basic demographic characteristics were recorded in a
medical questionnaire. The inclusion criteria for entering the
study were absence of any medical history or other neurologi-
cal, neurodegenerative or psychiatric disorders, as well as
absence of any medical history of cardiovascular, pulmonary,
renal and hepatic diseases, coagulopathies and any inﬂam-
matory conditions or immune diseases that could inﬂuence
TNF-a levels. The time interval between the onset of ICH and
the admission was less than 24 h in all patients. A detailed
neurological examination was performed on every patient by a
team of experienced neurologist and neurosurgeon. The
severity of the symptoms was estimated according to the
Canadian Stroke Scale (CSS).
Controls underwent detailed interview to exclude presence
of current or any past history of neurological, neurodegenera-
tive and mental diseases. Healthy controls were selected to
match patients according to gender and age, so that the effects
of these variables are excluded (Table 1).
2.2. Radiological analyses
Two CT scans were performed on all patients: at admission
and ﬁve days after ICH. The volume of the hematoma was
measured by performing transversal slices with slice thickness
of 3.5–10 mm. The calculations of the volume of the hematoma
and the edema were performed according to the ABC/2
formula, as described before [20]. Several patients had
irregular ICH volume and in this case, we have used the
calculator for irregular volumes [21,22]. The edema was
deﬁned as the most hypodense area immediately surrounding
the ICH and more hypodense than the corresponding area in
the contralateral hemisphere, according to the present
recommendations [23] and it was determined by subtracting
the volume of the ICH from that of the total lesion, as
performed in the previous studies [24,25] (given as supple-
mentary material).
2.3. Biochemical analyses
At admission, blood was collected in the morning (after
overnight fasting) in EDTA-anticoagulated tubes. The tubes
were centrifuged at 3,000 rpm, 15 min at +4 8C. The obtained
blood plasma was aliquoted and stored at 80 8C till further
analyses. The quantitative detection of glutamate and TNF-a
was performed using the ELISA kits from Abnova (Glutamate
ELISA Kit, KA1909) and Quantikine (Human TNF-alpha
Quantikine ELISA Kit, DTA00C), according to the manufac-
Table 1 – Baseline characteristics of patients and healthy
controls.
Variables Healthy
controls
Patients p-value
Number of subjects 50 50
Gender
Male 25 (50%) 25 (50%) n.s.a
Female 25 (50%) 25 (50%) n.s.a
Age
Less than 60 years 12 (24%) 9 (18%) n.s.a
60–70 years 25 (50%) 21 (42%) n.s.a
71–80 years 9 (18%) 13 (26%) n.s.a
More than 80 years 4 (8) 7 (14%) n.s.a
Systolic blood pressure
(mmHg)
125 (IQR = 10) 175 (IQR = 11) 0.02b
Diastolic blood pressure
(mmHg)
70 (IQR = 8) 100 (IQR = 11) 0.03b
Blood glucose levels
(mmol/L)
4.3 (IQR = 1.5) 7.6 (IQR = 1.7) 0.002b
CSS score at admission – 7.0 (IQR = 4.5) –
Anatomic localization of ICH
Lobar – 15 (30%) –
Deep (basal ganglia) – 35 (70%) –
Hemispheric side
Left – 26 (52%) –
Right – 24 (48%) –
Initial volume of ICH
(cm3)
– 25.1 (IQR = 42.3) –
Volume of the perifocal
edema after 5 days
(cm3)
– 33.8 (IQR = 48.9) –
a Calculated with contingency table and x2.
b Calculated with Mann–Whitney U test.
Fig. 1 – Peripheral blood plasma glutamate and TNF-a levels betw
of median blood plasma glutamate levels. (b) Histogram of the di
healthy controls. A good separation of the values can be observe
Histogram of the distribution of the values for TNF-a between p
values is evident. **p < 0.001.
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measured with according to the GLUCOSE GOD/PAP kit from
Biosystems.
2.4. Statistical analyses
The statistical analyses were performed using both the
statistical software IBM SPSS Statistics 21 and Statistica 7
(StatSoft©). Categorical variables are expressed as number of
subjects and %. Since the distribution of the values of all
continuous variables differed signiﬁcantly from normality,
these results are expressed as median and interquartile range
(IQR). The Mann–Whitney U-test was used to compare the
differences in the central tendencies between the groups, and
the non-parametric Levene test was used to test the
differences in the variances. Bivariate statistical analyses
were performed using non-parametric correlation with Spear-
man coefﬁcient. The multiple regression model was per-
formed after logarithmic transformation of the values. A
moderation analysis and two-way ANOVA was used for
estimating effects of interaction. In all cases, the level of
statistical signiﬁcance was deﬁned as p < 0.050, i.e. p < 0.001
for highly signiﬁcant.
3. Results
3.1. Blood plasma glutamate and TNF-a levels between
patients with ICH and healthy controls
Median blood plasma glutamate levels were signiﬁcantly
higher in patients with ICH, when compared to healthy
controls (U = 26.0, p = 3.2  1017; Fig. 1, panel a). Patients with
ICH had also signiﬁcantly higher levels of median bloodeen patients with ICH and healthy controls. (a) Comparison
stribution of the values for glutamate between patients and
d. (c) Comparison of median blood plasma TNF-a levels. (d)
atients and healthy controls. The good separation of the
nÞ
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We have observed very good separations of the values for
glutamate (Fig. 1, panel b) and especially TNF-a (panel d)
between the two groups.
Nevertheless, we have detected higher variability of the
glutamate and TNF-a values within the patient group. Patients
had 10 times bigger variability of the TNF-a levels (F = 79.7,
p = 2.58  1014). The differences in the IQR of the glutamate
levels were not that astounding, but were also proven
statistically signiﬁcant (F = 19.7, p = 0.00002). Both plasma
glutamate and TNF-a levels within the patient group did not
differ signiﬁcantly between males and females (U = 206.0,
p = 0.097 and U = 275.5, p = 0.473 respectively), nor between the
different age groups (x2 = 4.382, p = 0.289 and x2 = 5.167,
p = 0.160). Also, we did not detect any signiﬁcant differences
in the glutamate and TNF-a levels in patients with lobar and
deep ICH (U = 253.0, p = 0.841 and U = 228.0, p = 0.465 respec-
tively), as well as between patients that had ICH on the right or
the left hemisphere (U = 277.0, p = 0.646 and U = 284.5,
p = 0.593).
A negative and low correlation between the CSS scores for
symptom severity at admission and plasma glutamate levels
in ICH patients has been detected (r = 0.331; p = 0.019). The
correlation between the CSS scores and plasma TNF-a levels in
ICH patients was negative, moderate and statistically highly
signiﬁcant (r = 0.567; p = 0.00002). We have also detected
positive and moderate correlation between blood plasma
glutamate levels and the initial volume of ICH at admission
(r = 0.453, p = 0.00001). The correlation between the plasma
TNF-a levels and the initial volume of ICH was even higher
(r = 0.653, p = 2.7  107), suggesting that both of these vari-
ables are inﬂuenced by the initial volume of the hematoma.
3.2. Effects of the biochemical variables on the
development of the perifocal edema after 5 days
The results from the multiple regression model for the
inﬂuence of the followed variables on admission on the
development of the perifocal edema ﬁve days after ICH are
shown in Table 2.
Blood plasma glutamate and TNF-a levels as well as the
initial volume of ICH were estimated as the only signiﬁcantTable 2 – Multiple regression model for the development
of the perifocal edema five days after ICH. The values
were log transformed. Statistically significant predictors
are given in bold.
Independent predictors Standardized
b coefﬁcients
p-value
Gender 0.051 0.525
Anatomic localization of ICH 0.062 0.408
Hemispheric side 0.001 0.989
Systolic blood pressure (mmHg) 0.056 0.460
Diastolic blood pressure (mmHg) 0.089 0.259
Blood glucose levels (mmol/L) 0.043 0.394
Blood plasma glutamate levels
(mmol/L)
0.232 0.007
Blood plasma TNF-a levels (pg/mL) 0.423 0.00003
CSS score at admission 0.091 0.295
Initial volume of ICH at admission 0.409 0.00009predictors that inﬂuence the development of the perifocal
edema. According to the standardized b coefﬁcients, it seems
evident that the TNF-a levels have the strongest effect on the
volume of the edema.
The following equation for estimation of the perifocal
edema can be generated from the model:
Vðperifocal edema; 5th dayÞ ¼ 1:424
þ 0:423cðTNF-a at admissionÞ
þ 0:232cðglutamate at admissio
þ 0:409VðICH at admissionÞ
The predictive capacity of the generated model was
estimated as very high (R2 = 0.753, adjusted R2 = 0.736, stan-
dard error of estimate = 0.243) and with high degree of
signiﬁcance (ANOVA F = 46,626; p = 5.4  1014).
Bearing in mind that the main focus of this paper is the
effect of the biochemical variables and their possible role as
predictors for the development of the perifocal edema, we
have also performed a second analysis where the clinical and
radiological variables were omitted. These results are repre-
sented on the next table (Table 3).
The predictive capacity of the second generated model was
slightly lower, but still it was estimated as high (R2 = 0.654,
adjusted R2 = 0.639, standard error of estimate = 0.284), with
high degree of signiﬁcance (ANOVA F = 44.350, p = 1.5  1011).
According to the second model, once again the gender, the
anatomic localization of ICH, the hemispheric side with ICH,
the systolic blood pressure, the diastolic blood pressure and
the blood glucose levels were excluded as non-signiﬁcant
predictors for the development of the edema, However, the
effects of the TNF-a levels and glutamate were conﬁrmed as
signiﬁcant predictors, especially stressing the effect of the
TNF-a levels. The results from the proposed regression
analyses were modeled and depicted in Fig. 2.
3.3. Effects of interaction between blood plasma glutamate
and TNF-a levels on the volume of the perifocal edema ﬁve
days after ICH
The correlation between plasma glutamate and TNF-a at
admission in our patients with ICH was positive, low andTable 3 – Multiple regression model for the development
of the perifocal edema five days after ICH (clinical and
radiological variables are omitted). The values were log
transformed. Statistically significant predictors are given
in bold.
Independent predictors Standardized
b coefﬁcients
p-value
Gender 0.054 0.872
Anatomic localization of ICH 0.101 0.985
Hemispheric side with ICH 0.062 0.483
Systolic blood pressure (mmHg) 0.089 0.315
Diastolic blood pressure (mmHg) 0.093 0.315
Blood glucose levels (mmol/L) 0.011 0.899
Blood plasma TNF-a levels (pg/mL) 0.627 1.3 T 10S8
Blood plasma glutamate levels
(mmol/L)
0.339 0.001
Fig. 2 – Effects of blood plasma TNF-a and glutamate levels
on the volume of the perifocal edema five days after ICH.
The values were log transformed.
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the relation between these two variables has also been given a
low support (R2 = 0.132; Fig. 3, panel a). However, to test the
effects of their possible mutual interaction, we have per-
formed moderation analyses by multiplying the glutamate
and TNF-a levels. The results are represented in Table 4.
The multiplied TNF-a  glutamate variable was not
detected as a signiﬁcant predictor for the development of
the perifocal edema, which indicates absence of any interac-
tion between these variables.
Additionally, we have also performed two-way ANOVA
analyses. On the basis of the median values, the patients were
coded into two groups: patient subgroup with low and patient
subgroup with high glutamate and TNF-a levels. Then, the
effects of interaction of these variables were analyzed (low or
high levels) on the volume of the perifocal edema. ThisFig. 3 – Effects of interaction between blood plasma glutamate a
days after ICH. (a). Linear regression model for the relations betw
transformed). (b) Two-way ANOVA for estimating effects of inteanalysis again conﬁrmed absence of any signiﬁcant interac-
tion (F = 0.000, p = 0.999, Fig. 3, panel b).
4. Discussion
The detrimental effects of the excitotoxicity in the ischemic
stroke were a central subject for examination long years ago
[26], but the actual contribution of the glutamate in the brain
damage following hemorrhagic stroke started to be examined
in the last 10 years, with more or less contradictory ﬁndings in
spite with the other proposed mechanisms that were
commonly reported as primary triggers [27,28]. The ﬁrst report
for increased glutamate levels after ICH have been gained
using in vivo brain microdialysis in experimental animals with
induced ICH [16]. The authors in this study have detected
4 times higher glutamate levels ipsilateral to the hematoma
30 min after ICH that remained increased in the next 5 h.
However, only several studies have explored the role of the
blockade of the glutamate accumulation on brain injury after
ICH. Mendelow [29] has shown that D-CPP antagonist on the
NMDAR receptor can reduce the volume of the edema in
experimental animals. Moreover, it have also been reported
that the non-competitive antagonist of the NMDA receptor,
memantine, can reduce the expansion of the hematoma, the
cell death and the inﬁltration of immune cells [30].
Contrarily, the effects of TNF-a after ICH are well
documented. Recently, Behrouz [7] proposed a model for the
contribution of TNF-a on edema formation, based on the
previous results that the production of thrombin after ICH
triggers increase of the TNF-a brain levels [18]. It seems that
the increased TNF-a levels activate the receptors on the
microglia cells and astrocytes and are also involved in the
regulation of the permeability of the blood–brain barrier and
the glutaminergic transmission [31].
In the present study, we have shown higher blood plasma
glutamate and TNF-a levels in patients, when compared tond TNF-a levels on the volume of the perifocal edema five
een blood plasma glutamate and TNF-a levels (log
raction.
Table 4 – Moderation analysis for the effects of interaction
between glutamate and TNF-a on the volume of the
perifocal edema. Statistically significant predictors are
given in bold.
Independent predictors Standardized
b coefﬁcients
p-value
Blood plasma TNF-a levels
(pg/mL)
2.624 0.020
Blood plasma glutamate
levels (mmol/L)
0.884 0.001
Blood plasma
glutamate  TNF-a levels
2.246 0.152
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 2 0 7 – 2 1 4212healthy controls. It seems that these differences reﬂect
the brain abnormalities detected in animal models for ICH,
most probably because of the increased permeability of the
blood–brain barrier and their inﬂux in the blood. The good
separation of the values between patients and healthy
controls can clearly support the idea for their signiﬁcance
as peripheral markers for excitotoxicity and inﬂammation in
ICH patients.
However, only several studies have examined the periph-
eral blood levels of these two mediators in patients with ICH.
Hitherto, increased TNF-a levels at admission were detected
as predictors for increased mortality in patients at intensive
care [32]. High peripheral TNF-a levels were also reported as a
predictor for early hematoma growth and were associated
with increased risk for mortality and bad neurological
outcome after three months in patients with ICH [33]. Domac
et al. [34] have detected higher TNF-a levels in patients with
acute ischemic stroke, when compared to healthy controls. On
the basis of these ﬁndings, Maas and Furie [35] have listed TNF-
a as a molecular biomarker that cannot serve for distinction
between ischemic and hemorrhagic stroke and as a marker not
useful for early diagnosis of ICH but potentially useful for its
subacute diagnosis. Yang and Shao [36] have detected higher
levels of TNF-a in patients with hypertensive ICH at admis-
sion, when compared with healthy controls, with a peak of
the TNF-a concentration three days after ICH. However, the
studies for peripheral blood levels of glutamate in patients
with ICH are even scarcer; in this context Castillo et al. [25]
have revealed signiﬁcant differences in glutamate levels
between patients with good and bad neurological outcome,
but this study lacks any comparison of these values with
healthy controls.
We have also detected higher variability of glutamate and
TNF-a values within the patient group, but however we have
not revealed any signiﬁcant effects of the gender, age, the
anatomic localization of ICH and the hemispheric side on
this variability. Nevertheless, glutamate and TNF-a values
correlated with symptom severity and the initial volume of
ICH. These ﬁndings are in a good agreement with several
studies [25,36]. In our study, we have also assumed possible
contribution of the anatomic localization of ICH on the
peripheral levels of these two biochemical variables. However,
it was shown absence of any effect of the anatomic localization
of ICH on plasma glutamate and TNF-a levels. In line with
these ﬁndings, it seems that the symptom severity and the
initial volume of ICH are the major drivers for the variability of
the glutamate and TNF-a levels in patients with ICH.Concerning the effects of the clinical, biochemical and CT
variables on the volume of the perifocal edema, our developed
multiple regression model has revealed that the initial volume
of ICH, and both plasma glutamate and TNF-a levels are
signiﬁcant predictors that induce the development of the
perifocal edema. This result is not in an agreement with some
previous studies where TNF-a was estimated as the only
signiﬁcant biomarker for the volume of the perifocal edema
[25]. Nevertheless, the authors in the same paper show
positive correlation between blood plasma glutamate levels
and the volume of the edema, suggesting that both excito-
toxicity and inﬂammation contribute to the secondary brain
injury. In our study, we have shown absence of any effect of
interaction between these two mechanisms, which indicates
that both glutamate and TNF-a individually contribute to the
volume of the perifocal edema, with TNF-a being the strongest
predictor for its development. Once again, the anatomic
localization of ICH was not estimated as signiﬁcant predictor
for the formation of the edema.
These ﬁndings are in very good congruence with the
previously listed results from the animal models for ICH that
suggest possible contribution of glutamate and TNF-a in the
formation of the edema. For instance, Wu et al. [37] have
detected that perihematomal glutamate increased signiﬁcant-
ly after ICH and a strong association between these high levels
with BBB disruption and brain edema was detected, suggesting
that glutamate may play an important role in the secondary
brain injury. Two studies have also reported decreased levels
of perihematomal glutamate levels after minimally invasive
procedure for ICH evacuation in animal models [38,39]. In
animal models, increased levels of TNF-a were detected in the
perihematomal area that contribute to the development of the
edema via increased BBB permeability [40]. Bearing in mind the
high predictive capacity of the developed model, we propose
that it can be used in future for prediction of the volume of the
perifocal edema after ICH which, on the other side, can help in
the dilemma between conservative treatment and surgical
intervention.
5. Conclusions
In all, our results have shown that patients with ICH have
signiﬁcantly higher blood plasma glutamate and TNF-a levels
at admission, when compared to healthy controls, which
stresses the importance of these mediators in the pathology of
the ICH. The anatomic localization of ICH (lobar/deep; left/
right hemisphere) does not inﬂuence the inﬂux of glutamate
and TNF-a and equally induces excitotoxicity and inﬂamma-
tion, regardless ICH position.
The only signiﬁcant predictors for the formation of the
perifocal edema ﬁve days after ICH are the initial volume of the
ICH, the peripheral glutamate and TNF-a levels that indepen-
dently contribute (without any effect of interaction) to the
development of the edema, regardless the localization of the
ICH. These variables should be considered for prediction of the
volume of the perifocal edema after ICH which, on the other
side, can help in the dilemma between conservative treatment
and surgical intervention. The most powerful predictor for the
development of the edema are the TNF-a levels, which points
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 2 0 7 – 2 1 4 213to the fact that the inﬂammatory mechanisms have the
primary role for the formation of the edema and the secondary
brain injury. We believe that these results can contribute in the
prevention of the formation of big edema in patients with ICH,
as well as in the future development of different therapeutic
strategies via blockade of the glutamate and TNF-a receptors
and thus prevent their detrimental effects.
Conﬂict of interest
None declared.
Acknowledgement and ﬁnancial support
None declared.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.pjnns.2017.10.003.
r e f e r e n c e s
[1] Qureshi AI, Mendelow AD, Hanley DF. Intracerebral
haemorrhage. Lancet 2009;373:1632–44.
[2] Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of
ischemic and hemorrhagic stroke: incidence, prevalence,
mortality, and risk factors. Neurol Clin 2008;26:871–95.
[3] Jakubovic R, Aviv RI. Intracerebral hemorrhage: toward
physiological imaging of hemorrhage risk in acute and
chronic bleeding. Front Neurol 2012;3:86.
[4] Gebel Jr JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L,
Salisbury S, et al. Relative edema volume is a predictor of
outcome in patients with hyperacute spontaneous
intracerebral hemorrhage. Stroke 2002;33(11):2636–41.
[5] Siddique MS, Mendelow AD. Surgical treatment of
intracerebral haemorrhage. Br Med Bull 2000;56(2):444–56.
[6] Mendelow AD, Gregson BA, Fernandes HM, Murray GD,
Teasdale GM, Hope DT, et al. Early surgery versus initial
conservative treatment in patients with spontaneous
supratentorial intracerebral haematomas in the
International Surgical Trial in Intracerebral Haemorrhage
(STICH): a randomised trial. Lancet 2005;365(9457):387–97.
[7] Behrouz R. Re-exploring tumor necrosis factor alpha as a
target for therapy in intracerebral hemorrhage. Transl
Stroke Res 2016;(2):93–6.
[8] Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M.
Collagenase-induced intracerebral hemorrhage in rats.
Stroke 1990;21:801–7.
[9] Lei B, Sheng H, Wang H, Lascola CD, Warner DS, Laskowitz
DT, et al. Intrastriatal injection of autologous blood or
clostridial collagenase as murine models of intracerebral
hemorrhage. J Vis Exp )2014;(89).
[10] Wang J, Dore S. Inﬂammation after intracerebral
hemorrhage. J Cereb Blood Flow Metab 2007;27(5):894–908.
[11] Ziai WC. Hematology and inﬂammatory signaling of
intracerebral hemorrhage. Stroke 2013;44(6 Suppl. 1):S74–8.[12] Wang J. Preclinical and clinical research on
inﬂammation after intracerebral hemorrhage. Prog Neurobiol
2010;92:463–77.
[13] Zhang XM, Li XL, Tang SH, Liu QC. Effect of head
hypothermia on serum inﬂammatory cytokines levels in
patients with hypertensive intracerebral hemorrhage.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006;18(5):294–6.
[14] Rosell A, Vilalta A, Garcia-Berrocoso T, Fernandez-Cadenas
I, Domingues-Montanari S, Cuadrado E, et al. Brain
perihematoma genomic proﬁle following spontaneous
human intracerebral hemorrhage. PLoS ONE 2011;6(2):
e16750.
[15] MacLellan C, Peeling J, Colbourne F. Cytoprotection
strategies for experimental intracerebral hemorrhage. In:
Carhuapoma R, Mayer SA, Hanley DF, editors. Intracerebral
hemorrhage. Cambridge: Cambridge University Press; 2010.
[16] Qureshi AI, Ali Z, Suri MF, Shuaib A, Baker G, Todd K, et al.
Extracellular glutamate and other amino acids in
experimental intracerebral hemorrhage: an in vivo
microdialysis study. Crit Care Med 2003;31:1482–9.
[17] Wu G, Li S, Wang L, Mao Y. The perihematomal glutamate
level is associated with the outcome of patients with basal
ganglia hematomas treated by minimally invasive
procedures. Neurol Res 2013;35(8):829–36.
[18] Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of
edema formation after intracerebral hemorrhage: effects of
thrombin on cerebral blood ﬂow, blood–brain barrier
permeability, and cell survival in a rat model. J Neurosurg
1997;86(2):272–8.
[19] Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW,
Kistler JP, et al. The Harvard Cooperative Stroke Registry: a
prospective registry. Neurology 1978;28:754–62.
[20] Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR,
Zuccarello M, et al. The ABCs of measuring intracerebral
hemorrhage volumes. Stroke 1996;27(8):1304–5.
[21] Xu X, Chen X, Zhang J, Zheng Y, Sun G, Yu X, et al.
Comparison of the Tada formula with software slicer
precise and low-cost method for volume assessment of
intracerebral hematoma. Stroke 2014;45(11):3433–5.
[22] Stojanov D, Janković S, Ilić D, Benedeto-Stojanov D.
Comparison of elliptic equation – ABC/2 with computer
assisted semiautomatic methods for measuring the volume
of intracerebral hemorrhage. Acta Med Median 2015;54
(3):34–8.
[23] Urday S, Beslow LA, Goldstein DW, Vashkevich A, Ayres AM,
Battey TW, et al. Measurement of perihematomal edema in
intracerebral hemorrhage. Stroke 2015;46(4):1116–9.
[24] Gupta M, Verma R, Parihar A, Garg RK, Singh MK, Malhotra
HS. Perihematomal edema as predictor of outcome in
spontaneous intracerebral hemorrhage. J Neurosci Rural
Pract 2014;5(1):48–54.
[25] Castillo J, Dávalos A, Alvarez-Sabín J, Pumar JM, Leira R,
Silva Y, et al. Molecular signatures of brain injury after
intracerebral hemorrhage. Neurology 2002;58(4):624–9.
[26] Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation
of the extracellular concentrations of glutamate and
aspartate in rat hippocampus during transient cerebral
ischemia monitored by intracerebral microdialysis. J
Neurochem 1984;43:1369–74.
[27] Keep RF, Hua Y, Xi G. Intracerebral haemorrhage:
mechanisms of injury and therapeutic targets. Lancet
Neurol 2012;11(8):720–31.
[28] Wagner KR, Packard BA, Hall CL, Smulian AG, Linke MJ, De
Courten-Myers GM, et al. Protein oxidation and heme
oxygenase-1 induction in porcine white matter following
intracerebral infusions of whole blood or plasma. Dev
Neurosci 2002;24:154–60.
[29] Mendelow AD. Mechanisms of ischemic brain damage with
intracerebral hemorrhage. Stroke 1993;24(12 Suppl.):I115–7.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 2 0 7 – 2 1 4214[30] Lee ST, Chu K, Jung KH, Kim J, Kim EH, Kim SJ, et al.
Memantine reduces hematoma expansion in experimental
intracerebral hemorrhage, resulting in functional
improvement. J Cereb Blood Flow Metab 2006;26(4):536–44.
[31] McCoy MK, Tansey MG. TNF signaling inhibition in the CNS:
implications for normal brain function and
neurodegenerative disease. J Neuroinﬂammation 2008;5:45.
[32] Fang HY, Ko WJ, Lin CY. Inducible heat shock protein 70,
interleukin-18, and tumor necrosis factor alpha correlate
with outcomes in spontaneous intracerebral hemorrhage. J
Clin Neurosci 2007;14:435–41.
[33] Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A.
Molecular signatures of vascular injury are associated with
early growth of intracerebral hemorrhage. Stroke
2005;36:86–91.
[34] Domac FM, Somay G, Misirli H, Erenoglu NY. Tumor
necrosis factor alpha serum levels and inﬂammatory
response in acute ischemic stroke. Neurosciences (Riyadh)
2007;12(1):25–30.
[35] Maas MB, Furie KL. Molecular biomarkers in stroke
diagnosis and prognosis. Biomark Med 2009;3(4):363–83.[36] Yang G, Shao GF. Elevated serum IL-11, TNF a, and VEGF
expressions contribute to the pathophysiology of
hypertensive intracerebral hemorrhage (HICH). Neurol Sci
2016;37(8):1253–9.
[37] Wu G, Sun S, Sheng F, Wang L, Wang F. Perihematomal
glutamate level is associated with the blood–brain barrier
disruption in a rabbit model of intracerebral hemorrhage.
Springerplus 2013;2:358.
[38] Wu G, Sheng F, Wang L, Wang F. The pathophysiological
time window study of performing minimally invasive
procedures for the intracerebral hematoma evacuation in
rabbit. Brain Res 2012;1465:57–65.
[39] Wu G, Wang L, Wang F, Feng A, Sheng F. Minimally invasive
procedures for intracerebral hematoma evacuation in early
stages decrease perihematomal glutamate level and
improve neurological function in a rabbit model of ICH.
Brain Res 2013;1492:140–7.
[40] Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition
of tumor necrosis factor-a (TNF-a) activity in rat brain is
associated with cerebroprotection after closed head injury.
J Cereb Blood Flow Metab 1996;16:378–438.
